An investigation for investors in shares NASDAQ:ZSAN was announced over potential breaches of fiduciary duties by certain Zosano Pharma directors.
Investors who purchased shares of Zosano Pharma Corp (NASDAQ:ZSAN) have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Zosano Pharma directors breached their fiduciary duties and caused damage to the company and its shareholders.
Fremont, CA based Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company that has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Zosano Pharma Corp went public in January 2015 and shares of Zosano Pharma Corp (NASDAQ:ZSAN) grew to as high as $11.67 per share in March 2015. Since then shares of Zosano Pharma Corp (NASDAQ:ZSAN) declined to as low as $1.95 per share on January 22, 2016.
Those who purchased NASDAQ:ZSAN shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego